RheoGene, Inc. Introduces AttSite(TM) Recombinases
10/19/2005 5:10:20 PM
NORRISTOWN, PA -- (MARKET WIRE) -- 05/10/2005 -- RheoGene Inc., a biotechnology developer of products and technologies that regulate gene expression, announces the introduction of AttSite Recombinases, novel gene-targeting enzymes that direct site-specific DNA modification in a wide range of organisms. Each enzyme catalyzes the irreversible integration or excision of DNA sequences at specific locations within the genome, with broad applications in functional genomics, transgenics technology, biotherapeutic protein production and stem cell and gene therapy.
comments powered by